OptumRx Revenue and Competitors
Estimated Revenue & Valuation
- OptumRx's estimated annual revenue is currently $492k per year.
- OptumRx's estimated revenue per employee is $123,000
Employee Data
- OptumRx has 4 Employees.
- OptumRx grew their employee count by 0% last year.
OptumRx's People
| Name | Title | Email/Phone |
|---|
OptumRx Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $6.5M | 33 | -13% | N/A | N/A |
#2 | $149.4M | 486 | N/A | N/A | N/A |
#3 | $13.9M | 63 | -25% | N/A | N/A |
#4 | $8.3M | 42 | 8% | N/A | N/A |
#5 | $2.5M | 17 | 0% | N/A | N/A |
#6 | $23.1M | 94 | N/A | N/A | N/A |
#7 | $11.3M | 51 | 2% | N/A | N/A |
#8 | $411.6M | 1195 | N/A | N/A | N/A |
#9 | $40.9M | 151 | 15% | N/A | N/A |
#10 | $43.8M | 162 | -6% | N/A | N/A |
What Is OptumRx?
OptumRx is more than just a mail order pharmacy. We are a focused, collaborative, and innovative leader in the pharmacy benefit management (PBM) industry. Today, we serve more than 13.5 million people through our state-of-the-art mail service pharmacies and a national network of more than 67,000 community pharmacies. We manage prescription drug benefits of commercial, Medicare, and government health plans, and those of employers and unions.
keywords:N/A
N/A
Total Funding
4
Number of Employees
$492k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
OptumRx News
The so-called medical-loss ratio (MLR) doesn't apply to Optum Rx, ... Ohio Attorney General Dave Yost sued OptumRx in 2019 to recover nearly...
UnitedHealthcare, OptumRx Sued Over Alleged 'Spread Pricing' For Drugs. Louisiana accused them of overcharging the state's Medicaid department...
Louisiana's attorney general sued UnitedHealth Group's OptumRx and UnitedHealthcare businesses, alleging the pharmacy benefit manager and...
Other Companies in Irvine
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.1M | 4 | -64% | $6.1M |
#2 | $0.3M | 4 | N/A | N/A |
#3 | $0.3M | 4 | N/A | N/A |
#4 | $0.3M | 4 | N/A | N/A |
#5 | $0.4M | 4 | 0% | N/A |